Overview

A Study of Caffeine on Cardiac Arrhythmias

Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
Stimulants and drugs are often associated with cardiac effects. Caffeine, a therapeutic xanthine, has been described as a sympathomimetic and has shown to have stimulatory effects on the heart. Patients with symptomatic cardiac arrhythmias are generally informed by their physician to stop or significantly reduce caffeine intake. However, in spite of numerous reports that have reviewed the cardiac effects of caffeine, it remains unclear to what extent this stimulant may be detrimental, and what subgroups of patients may be most vulnerable. The investigators propose to evaluate the effects of caffeine in patients with previously diagnosed cardiac arrhythmias. The results of our report will provide important new information for physicians and patients regarding the effects of caffeine on symptomatic cardiac arrhythmias.
Phase:
N/A
Details
Lead Sponsor:
Ottawa Heart Institute Research Corporation
Treatments:
Caffeine